All Articles by Author:

Noshin Noorjahan

RNA Neoantigen Vaccines Prime Long-Lived CD8+ T Cells in Pancreatic Cancer

[Nature] A fundamental challenge for cancer vaccines is to generate long-lived functional T cells that are specific for tumor antigens. Investigators found that mRNA–lipoplex vaccines against somatic mutation-derived neoantigens may solve this challenge in pancreatic ductal adenocarcinoma.

AAV1.NT3 Gene Therapy Mitigates the Severity of Autoimmune Encephalomyelitis in the Mouse Model for Multiple Sclerosis

[Gene Therapy] scAAV1.tMCK.NT-3 was delivered to the gastrocnemius muscle of experimental autoimmune encephalomyelitis (EAE) mice, the chronic relapsing mouse model of multiple sclerosis, at three weeks post EAE induction.

Immunogenicity and Safety of a Live-Attenuated SARS-CoV-2 Vaccine Candidate Based on Multiple Attenuation Mechanisms

[eLife] Researchers constructed a live-attenuated vaccine candidate, BK2102, combining naturally occurring virulence-attenuating mutations in the NSP14, NSP1, spike, and ORF7-8 coding regions.

Activation of CXCR3+ Tfh Cells and B Cells in Lymph Nodes During Acute HIV-1 Infection Correlates with HIV-Specific Antibody Development

[Journal of Virology] To understand how Tfh/GC B-cell interactions during acute HIV-1 infection (AHI) impact the generation of HIV-specific antibodies, researchers performed a unique cross-sectional analysis of inguinal lymph node biopsies taken prior to antiretroviral therapy initiation in AHI.

Necrosis Drives Susceptibility to Mycobacterium tuberculosis in PolgD257A Mutator Mice

[Infection and Immunity] The authors reported that mutations in mitochondria DNA polymerase gamma potentiate susceptibility to Mycobacterium tuberculosis infection in mice.

Systemic Inflammation Is Associated with Worse Outcomes from SARS-CoV-2 Infection but Not Neutralizing Antibody

[Microbiology Spectrum] Scientists determined the association between neutralizing antibody responses, inflammation, and clinical outcomes in hospitalized patients with COVID-19.

Popular

Doublecortin Restricts Neuronal Branching by Regulating Tubulin Polyglutamylation

[Nature Communications] Researchers used CRISPR/Cas9 to knock-out the Doublecortin gene in iPSCs and differentiated the cells into cortical neurons. DCX-KO neurons showed reduced velocities of nuclear movements and an increased number of neurites early in neuronal development.

Pluristyx Enables Safer, Universal Cell Therapy Solutions with Newly Issued US Patent for iACT Stealth™ Technology

[Pluristyx] Pluristyx announced the issuance of the induced Allogeneic Cell Tolerance (iACT Stealth) US Patent No. 12,178,835. This patent marks a significant milestone in Pluristyx's mission to bring advanced cell therapy solutions to the global market.

Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US

[The Canadian Press] The Bahrain Oncology Centre has made medical history by successfully treating a sickle cell disease patient using CRISPR-based gene-editing therapy, Casgevy. This marks the first successful treatment of its kind outside the United States.